Tag: Telix Pharmaceuticals
Sidley guides USD2.1bn Telix radiopharmaceutical collaboration
Sidley Austin advises Australia-based Telix Pharmaceuticals on its USD2.1 billion strategic collaboration with American biotech Regeneron
Sidley Austin advises Australia-based Telix Pharmaceuticals on its USD2.1 billion strategic collaboration with American biotech Regeneron
While stock exchanges lower barriers to atrract emerging sector issuers, regulators focus on accountability of listco and intermediaries at the top corporate level
Following months of market research, we have selected these outstanding in-house counsel and their teams